Concepedia

Publication | Closed Access

Pilot Study of 19 Patients with Severe Pemphigus: Prophylactic Treatment with Rituximab Does Not Appear to be Beneficial

DOI

40

Citations

35

References

2014

Year

Stamatios Gregoriou, S. Giatrakou, Konstantinos Theodoropoulos, A.C. Katoulis, Panagiota Loumou, E. Toumbis-Ioannou, Evangelia Papadavid, Georgia Avgerinou, Nikolaos Stavrianeas, Dimitris Rigopoulos
Dermatology

Abstract

One course of rituximab and treatment of relapses is highly effective and well tolerated in the treatment of refractory pemphigus. In this pilot study of 19 patients, the prophylactic infusion does not appear to have provided any additional benefit to the patients receiving it.

References

YearCitations

Page 1